Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 406,704 | 674,493 | 76,644 | 156,074 | 108,624 |
| Marketable Securities | 27,483 | 10,435 | 2,997 | N/A | N/A |
| Receivables | 23,296 | 3,570 | N/A | 524 | 1,000 |
| Inventories | 7,584 | 2,611 | N/A | N/A | N/A |
| Other current assets | 580 | 0 | 0 | 0 | 0 |
| TOTAL | $488,145 | $704,645 | $87,910 | $166,792 | $114,763 |
| Non-Current Assets | |||||
| PPE Net | 2,944 | 3,300 | 2,497 | 2,071 | 1,273 |
| Other Non-Current Assets | 28,922 | 17,082 | 15,519 | 4,114 | 3,065 |
| TOTAL | $31,866 | $20,382 | $18,016 | $6,185 | $4,338 |
| Total Assets | $520,011 | $725,027 | $105,926 | $172,977 | $119,101 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 6,142 | N/A |
| Accounts payable and accrued liabilities | 12,643 | 18,352 | 15,349 | 12,096 | 6,820 |
| Accrued Expenses | 68,594 | 44,612 | 29,060 | 53,735 | 30,265 |
| Other current liabilities | 66,381 | 116,005 | N/A | N/A | N/A |
| TOTAL | $250,330 | $281,340 | $85,925 | $71,973 | $37,085 |
| Non-Current Liabilities | |||||
| Long Term Debt | 358,700 | 358,700 | 113,700 | 93,240 | 43,624 |
| Deferred Revenues | 100,564 | 100,564 | 40,000 | N/A | N/A |
| Other Non-Current Liabilities | 8,752 | 41,583 | 14,578 | 2,273 | 255 |
| TOTAL | $743,158 | $797,652 | $128,278 | $96,670 | $44,287 |
| Total Liabilities | $993,488 | $1,078,992 | $214,203 | $168,643 | $81,372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,332 | 91,480 | 89,869 | 72,198 | 64,875 |
| Common Shares | 2 | 2 | 2 | 1 | 1 |
| Retained earnings | -1,252,129 | -1,046,148 | -791,014 | -502,025 | -228,474 |
| Other shareholders' equity | -17,285 | -17,285 | -1,646 | 507 | 24 |
| TOTAL | $-473,477 | $-353,965 | $-108,277 | $4,334 | $37,729 |
| Total Liabilities And Equity | $520,011 | $725,027 | $105,926 | $172,977 | $119,101 |